AlzChem Group AG
XETRA:ACT

Watchlist Manager
AlzChem Group AG Logo
AlzChem Group AG
XETRA:ACT
Watchlist
Price: 58 EUR 1.75% Market Closed
Market Cap: 590.2m EUR
Have any thoughts about
AlzChem Group AG?
Write Note

Intrinsic Value

The intrinsic value of one ACT stock under the Base Case scenario is 92.7 EUR. Compared to the current market price of 58 EUR, AlzChem Group AG is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACT Intrinsic Value
92.7 EUR
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AlzChem Group AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ACT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ACT?
Bearish
Neutral
Bullish

Fundamental Analysis

58 EUR
+1.75%
+1.75%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AlzChem Group AG
DE
Chemicals
Market Cap
590.2m EUR
IPO
Jun 1, 1999
Employees
1 636
Germany
Market Cap
590.2m EUR
Industry
Chemicals
IPO
Jun 1, 1999
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about AlzChem Group AG

Provide an overview of the primary business activities
of AlzChem Group AG.

What unique competitive advantages
does AlzChem Group AG hold over its rivals?

What risks and challenges
does AlzChem Group AG face in the near future?

Has there been any significant insider trading activity
in AlzChem Group AG recently?

Summarize the latest earnings call
of AlzChem Group AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AlzChem Group AG.

Provide P/S
for AlzChem Group AG.

Provide P/E
for AlzChem Group AG.

Provide P/OCF
for AlzChem Group AG.

Provide P/FCFE
for AlzChem Group AG.

Provide P/B
for AlzChem Group AG.

Provide EV/S
for AlzChem Group AG.

Provide EV/GP
for AlzChem Group AG.

Provide EV/EBITDA
for AlzChem Group AG.

Provide EV/EBIT
for AlzChem Group AG.

Provide EV/OCF
for AlzChem Group AG.

Provide EV/FCFF
for AlzChem Group AG.

Provide EV/IC
for AlzChem Group AG.

Show me price targets
for AlzChem Group AG made by professional analysts.

What are the Revenue projections
for AlzChem Group AG?

How accurate were the past Revenue estimates
for AlzChem Group AG?

What are the Net Income projections
for AlzChem Group AG?

How accurate were the past Net Income estimates
for AlzChem Group AG?

What are the EPS projections
for AlzChem Group AG?

How accurate were the past EPS estimates
for AlzChem Group AG?

What are the EBIT projections
for AlzChem Group AG?

How accurate were the past EBIT estimates
for AlzChem Group AG?

Compare the revenue forecasts
for AlzChem Group AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AlzChem Group AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AlzChem Group AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of AlzChem Group AG compared to its peers.

Compare the P/E ratios
of AlzChem Group AG against its peers.

Discuss the investment returns and shareholder value creation
comparing AlzChem Group AG with its peers.

Analyze the financial leverage
of AlzChem Group AG compared to its main competitors.

Show all profitability ratios
for AlzChem Group AG.

Provide ROE
for AlzChem Group AG.

Provide ROA
for AlzChem Group AG.

Provide ROIC
for AlzChem Group AG.

Provide ROCE
for AlzChem Group AG.

Provide Gross Margin
for AlzChem Group AG.

Provide Operating Margin
for AlzChem Group AG.

Provide Net Margin
for AlzChem Group AG.

Provide FCF Margin
for AlzChem Group AG.

Show all solvency ratios
for AlzChem Group AG.

Provide D/E Ratio
for AlzChem Group AG.

Provide D/A Ratio
for AlzChem Group AG.

Provide Interest Coverage Ratio
for AlzChem Group AG.

Provide Altman Z-Score Ratio
for AlzChem Group AG.

Provide Quick Ratio
for AlzChem Group AG.

Provide Current Ratio
for AlzChem Group AG.

Provide Cash Ratio
for AlzChem Group AG.

What is the historical Revenue growth
over the last 5 years for AlzChem Group AG?

What is the historical Net Income growth
over the last 5 years for AlzChem Group AG?

What is the current Free Cash Flow
of AlzChem Group AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for AlzChem Group AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AlzChem Group AG

Current Assets 242m
Cash & Short-Term Investments 36m
Receivables 108.6m
Other Current Assets 97.4m
Non-Current Assets 205.8m
Long-Term Investments 6k
PP&E 181.6m
Intangibles 3.8m
Other Non-Current Assets 20.5m
Current Liabilities 95.8m
Other Current Liabilities 95.8m
Non-Current Liabilities 173m
Other Non-Current Liabilities 173m
Efficiency

Earnings Waterfall
AlzChem Group AG

Revenue
558m EUR
Cost of Revenue
-199m EUR
Gross Profit
359m EUR
Operating Expenses
-283.2m EUR
Operating Income
75.8m EUR
Other Expenses
-25.7m EUR
Net Income
50.1m EUR

Free Cash Flow Analysis
AlzChem Group AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ACT Profitability Score
Profitability Due Diligence

AlzChem Group AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Exceptional ROE
Positive Free Cash Flow
58/100
Profitability
Score

AlzChem Group AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

ACT Solvency Score
Solvency Due Diligence

AlzChem Group AG's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Short-Term Solvency
High Altman Z-Score
73/100
Solvency
Score

AlzChem Group AG's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACT Price Targets Summary
AlzChem Group AG

Wall Street analysts forecast ACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACT is 75.42 EUR with a low forecast of 72.72 EUR and a high forecast of 81.38 EUR.

Lowest
Price Target
72.72 EUR
25% Upside
Average
Price Target
75.42 EUR
30% Upside
Highest
Price Target
81.38 EUR
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ACT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ACT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ACT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ACT stock?

The intrinsic value of one ACT stock under the Base Case scenario is 92.7 EUR.

Is ACT stock undervalued or overvalued?

Compared to the current market price of 58 EUR, AlzChem Group AG is Undervalued by 37%.

Back to Top